Mohammad H Moussavian, MD
Neurology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Moussavian’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G84562 · Current
Licensed to practise in California · since 1998 · expires 2028-05-31 · State University of New York Health Science Center at Syracuse.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$18,674
Medicare paid this office $18,674 for 139 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 50 | $4,861 | $80 |
| Return visit (30+ min) | 38 | $4,364 | $101 |
| New patient visit (45+ min) | 24 | $3,324 | $138 |
| New patient visit (30+ min) | 29 | $2,732 | $94 |
| Long return visit (40+ min) | 15 | $2,401 | $160 |
Who their Medicare patients are
139 Original Medicare patients in 2024. Average age 77 · Women 54% · Also on Medicaid 17% · Health risk score 1.35. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Diabetes 38% · Chronic kidney disease 29% · Dementia 29% · Coronary heart disease 24% · Cancer 21% · Stroke 20% · Atrial fibrillation 19% · Depression 17% · Heart failure 13% · COPD 10%.
The office billed $80,576, Medicare allowed $27,132 and paid $18,674; for 178 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 139 | 178 | 77 | 1.35 | $80,576 | $18,674 |
| 2023 | 144 | 197 | 77 | 1.27 | $91,770 | $22,172 |
| 2022 | 108 | 128 | 77 | 1.18 | $57,284 | $14,776 |
| 2018 | 20 | 141 | 68 | 1.45 | $21,346 | $4,589 |
| 2017 | 11 | 11 | 72 | 1.19 | $2,067 | $382 |
| 2016 | 15 | 17 | 64 | 1.63 | $4,427 | $1,014 |
| 2015 | 15 | 16 | 68 | 2.43 | $4,334 | $1,226 |
| 2014 | 19 | 24 | 62 | 2.00 | $6,545 | $1,756 |
| 2013 | 13 | 13 | 77 | 2.04 | $3,796 | $1,143 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 38 | $5,254 | $109 |
| New patient visit (45+ min) | 37 | $5,023 | $136 |
| New patient visit (30+ min) | 44 | $4,418 | $100 |
| Short return visit (20+ min) | 41 | $3,994 | $85 |
| New patient visit (60+ min) | 11 | $2,238 | $203 |
2022: 4 services
| New patient visit (45+ min) | 38 | $5,664 | $149 |
| New patient visit (30+ min) | 40 | $4,268 | $107 |
| Return visit (30+ min) | 17 | $2,441 | $122 |
| Short return visit (20+ min) | 15 | $1,307 | $87 |
Medicaid work
$18,247 in 2022
Medicaid paid $18,247 for 128 billed services this clinician did in 2022, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 92 | $18,247 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 15 | $0 |
| Return visit (30+ min) | 21 | $0 |
| 2022 | 128 | 3 | 30 | $18,247 |
Drugs they prescribed that Part D paid
$21,545
Pharmacies billed $21,545 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 421) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
412 generic and fewer than 11 brand-name prescriptions · $21,545 in drug cost · 14 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levetiracetam | 34 | $1,654 | $49 |
| Donepezil | 99 | $1,284 | $13 |
| Carbidopa-Levodopa Er | 14 | $1,154 | $82 |
| Gabapentin | 61 | $1,136 | $19 |
| Memantine | 37 | $828 | $22 |
See all 8 drugs
| Levetiracetam | 34 | $1,654 | $49 |
| Donepezil | 99 | $1,284 | $13 |
| Carbidopa-Levodopa Er | 14 | $1,154 | $82 |
| Gabapentin | 61 | $1,136 | $19 |
| Memantine | 37 | $828 | $22 |
| Carbidopa-Levodopa | 32 | $769 | $24 |
| Quetiapine | 14 | $300 | $21 |
| Topiramate | 14 | $115 | $8 |
Year by year
| 2024 | 421 | 126 | 0% (0) | None | $21,545 |
| 2023 | 428 | 127 | 0% (0) | 3% | $30,186 |
| 2022 | 509 | 159 | None | 4% | $53,583 |
| 2021 | 470 | 178 | 0% (0) | 6% | $67,359 |
| 2020 | 915 | 245 | None | None | $277,383 |
| 2019 | 846 | 194 | None | 7% | $315,174 |
| 2018 | 860 | 196 | None | None | $310,353 |
| 2017 | 920 | 198 | None | 8% | $406,003 |
| 2016 | 999 | 213 | None | None | $350,181 |
| 2015 | 977 | 237 | None | None | $369,266 |
| 2014 | 971 | 226 | None | None | $448,341 |
| 2013 | 908 | 206 | 1% (12) | None | $339,915 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Gabapentin | 55 | $2,357 | $43 |
| Donepezil | 119 | $2,081 | $17 |
| Levetiracetam | 24 | $1,962 | $82 |
| Carbidopa-Levodopa Er | 16 | $1,957 | $122 |
| Memantine | 24 | $1,881 | $78 |
| Carbidopa-Levodopa | 46 | $1,552 | $34 |
| Primidone | 14 | $436 | $31 |
| Clopidogrel | 15 | $203 | $14 |
| Quetiapine | 13 | $97 | $7 |
2022: 13 drugs
| Nurtec Odt | 12 | $19,038 | $1,587 |
| Rivastigmine | 17 | $5,653 | $333 |
| Gabapentin | 72 | $2,784 | $39 |
| Carbidopa-Levodopa | 69 | $2,401 | $35 |
| Carbidopa-Levodopa Er | 26 | $1,963 | $76 |
| Levetiracetam | 28 | $1,767 | $63 |
| Donepezil | 58 | $813 | $14 |
| Memantine | 18 | $796 | $44 |
| Sumatriptan | 11 | $492 | $45 |
| Baclofen | 18 | $377 | $21 |
| Primidone | 20 | $336 | $17 |
| Amitriptyline | 12 | $194 | $16 |
| Clopidogrel | 12 | $172 | $14 |
2021: 8 drugs
| Levetiracetam | 66 | $9,911 | $150 |
| Carbidopa-Levodopa | 92 | $8,450 | $92 |
| Divalproex | 17 | $2,553 | $150 |
| Carbidopa-Levodopa Er | 28 | $2,254 | $81 |
| Gabapentin | 48 | $1,779 | $37 |
| Pramipexole Dihydrochloride | 16 | $454 | $28 |
| Lamotrigine | 19 | $412 | $22 |
| Topiramate | 12 | $333 | $28 |
2020: 23 drugs
| Glatopa | None | 12 | $18,528 | $1,544 |
| Carbidopa-Levodopa | None | 158 | $16,828 | $107 |
| Rytary | Parkinson's | 11 | $15,631 | $1,421 |
| Levetiracetam | None | 101 | $12,994 | $129 |
| Dalfampridine Er | None | 14 | $8,328 | $595 |
| Gabapentin | None | 100 | $4,352 | $44 |
| Carbidopa-Levodopa Er | None | 40 | $2,875 | $72 |
| Primidone | None | 37 | $2,692 | $73 |
| Pyridostigmine | None | 12 | $2,291 | $191 |
| Divalproex | None | 23 | $1,890 | $82 |
| Phenytoin Sodium Extended | None | 14 | $1,166 | $83 |
| Lamotrigine | None | 37 | $1,058 | $29 |
| Baclofen | None | 15 | $991 | $66 |
| Propranolol | None | 13 | $846 | $65 |
| Topiramate | None | 21 | $770 | $37 |
| Pramipexole Dihydrochloride | None | 21 | $561 | $27 |
| Clonazepam | None | 25 | $483 | $19 |
| Ropinirole | None | 18 | $478 | $27 |
| Sertraline | None | 14 | $268 | $19 |
| Diazepam | None | 20 | $260 | $13 |
| Donepezil | None | 12 | $177 | $15 |
| Trazodone | None | 14 | $173 | $12 |
| Lorazepam | None | 16 | $126 | $8 |
2019: 19 drugs
| Glatopa | 11 | $16,238 | $1,476 |
| Carbidopa-Levodopa | 144 | $14,568 | $101 |
| Levetiracetam | 122 | $7,615 | $62 |
| Primidone | 39 | $3,301 | $85 |
| Gabapentin | 65 | $3,042 | $47 |
| Carbidopa-Levodopa Er | 42 | $2,780 | $66 |
| Levetiracetam Er | 12 | $1,672 | $139 |
| Baclofen | 21 | $1,390 | $66 |
| Divalproex | 12 | $1,371 | $114 |
| Propranolol Hcl Er | 11 | $1,342 | $122 |
| Propranolol | 12 | $755 | $63 |
| Topiramate | 14 | $742 | $53 |
| Clonazepam | 44 | $646 | $15 |
| Pramipexole Dihydrochloride | 26 | $641 | $25 |
| Lamotrigine | 25 | $615 | $25 |
| Ropinirole | 13 | $472 | $36 |
| Sertraline | 20 | $387 | $19 |
| Sumatriptan | 12 | $125 | $10 |
| Lorazepam | 14 | $117 | $8 |
2018: 19 drugs
| Carbidopa-Levodopa | 150 | $19,017 | $127 |
| Carbidopa | 14 | $16,992 | $1,214 |
| Levetiracetam | 76 | $7,164 | $94 |
| Carbidopa-Levodopa Er | 65 | $3,590 | $55 |
| Gabapentin | 64 | $3,367 | $53 |
| Primidone | 35 | $2,493 | $71 |
| Propranolol Hcl Er | 16 | $1,821 | $114 |
| Divalproex | 18 | $1,534 | $85 |
| Levetiracetam Er | 14 | $1,475 | $105 |
| Lamotrigine | 31 | $1,155 | $37 |
| Baclofen | 16 | $1,064 | $66 |
| Propranolol | 12 | $978 | $82 |
| Topiramate | 17 | $660 | $39 |
| Ropinirole | 13 | $575 | $44 |
| Sertraline | 30 | $565 | $19 |
| Pramipexole Dihydrochloride | 23 | $531 | $23 |
| Clonazepam | 43 | $412 | $10 |
| Trazodone | 11 | $148 | $13 |
| Lorazepam | 16 | $115 | $7 |
2017: 19 drugs
| Tecfidera | 11 | $72,132 | $6,557 |
| Carbidopa-Levodopa | 185 | $25,959 | $140 |
| Levetiracetam | 82 | $9,317 | $114 |
| Carbidopa-Levodopa Er | 101 | $5,500 | $54 |
| Gabapentin | 66 | $4,139 | $63 |
| Primidone | 35 | $2,069 | $59 |
| Phenytoin Sodium Extended | 11 | $1,731 | $157 |
| Divalproex | 18 | $1,561 | $87 |
| Propranolol | 19 | $1,528 | $80 |
| Propranolol Hcl Er | 11 | $1,507 | $137 |
| Ropinirole | 30 | $1,273 | $42 |
| Baclofen | 12 | $1,029 | $86 |
| Pramipexole Dihydrochloride | 34 | $815 | $24 |
| Lamotrigine | 24 | $807 | $34 |
| Topiramate | 13 | $571 | $44 |
| Clonazepam | 33 | $378 | $11 |
| Nortriptyline | 11 | $334 | $30 |
| Fluoxetine | 14 | $197 | $14 |
| Lorazepam | 11 | $93 | $8 |
2016: 24 drugs
| Carbidopa-Levodopa | 201 | $29,875 | $149 |
| Levetiracetam | 103 | $13,543 | $131 |
| Entacapone | 13 | $8,351 | $642 |
| Carbidopa-Levodopa Er | 89 | $6,934 | $78 |
| Gabapentin | 52 | $5,151 | $99 |
| Primidone | 43 | $3,386 | $79 |
| Ropinirole | 36 | $3,132 | $87 |
| Amantadine | 13 | $2,569 | $198 |
| Propranolol Hcl Er | 12 | $2,270 | $189 |
| Divalproex | 15 | $1,482 | $99 |
| Pramipexole Dihydrochloride | 37 | $1,394 | $38 |
| Propranolol | 18 | $1,337 | $74 |
| Lamotrigine | 30 | $1,197 | $40 |
| Topiramate | 15 | $699 | $47 |
| Baclofen | 18 | $698 | $39 |
| Donepezil | 22 | $650 | $30 |
| Sertraline | 13 | $418 | $32 |
| Nortriptyline | 16 | $391 | $24 |
| Sumatriptan | 12 | $341 | $28 |
| Clonazepam | 14 | $286 | $20 |
| Quetiapine | 15 | $285 | $19 |
| Fluoxetine | 17 | $238 | $14 |
| Trazodone | 13 | $198 | $15 |
| Lorazepam | 11 | $79 | $7 |
2015: 23 drugs
| Xenazine | 11 | $147,223 | $13,384 |
| Carbidopa-Levodopa | 189 | $26,735 | $141 |
| Entacapone | 12 | $12,559 | $1,047 |
| Levetiracetam | 80 | $9,661 | $121 |
| Gabapentin | 68 | $7,888 | $116 |
| Carbidopa-Levodopa Er | 70 | $5,195 | $74 |
| Propranolol Hcl Er | 20 | $4,007 | $200 |
| Ropinirole | 38 | $3,212 | $85 |
| Primidone | 43 | $3,083 | $72 |
| Sumatriptan | 15 | $2,635 | $176 |
| Amantadine | 18 | $1,569 | $87 |
| Pramipexole Dihydrochloride | 30 | $1,418 | $47 |
| Divalproex | 13 | $1,245 | $96 |
| Lamotrigine | 31 | $1,237 | $40 |
| Topiramate | 23 | $1,189 | $52 |
| Donepezil | 19 | $962 | $51 |
| Propranolol | 20 | $917 | $46 |
| Baclofen | 11 | $365 | $33 |
| Clonazepam | 19 | $351 | $18 |
| Nortriptyline | 16 | $326 | $20 |
| Fluoxetine | 17 | $235 | $14 |
| Trazodone | 12 | $163 | $14 |
| Lorazepam | 11 | $78 | $7 |
2014: 29 drugs
| Xenazine | 11 | $117,823 | $10,711 |
| Avonex | 17 | $75,133 | $4,420 |
| Copaxone | 14 | $61,593 | $4,400 |
| Avonex | 12 | $52,821 | $4,402 |
| Carbidopa-Levodopa | 170 | $23,762 | $140 |
| Gabapentin | 71 | $8,142 | $115 |
| Ropinirole | 46 | $7,364 | $160 |
| Levetiracetam | 55 | $6,681 | $121 |
| Carbamazepine | 13 | $4,965 | $382 |
| Carbidopa-Levodopa Er | 47 | $4,598 | $98 |
| Sumatriptan | 15 | $4,270 | $285 |
| Pyridostigmine | 11 | $3,140 | $285 |
| Primidone | 39 | $3,123 | $80 |
| Propranolol Hcl Er | 15 | $2,826 | $188 |
| Pramipexole Dihydrochloride | 33 | $2,065 | $63 |
| Divalproex | 12 | $1,590 | $133 |
| Topiramate | 19 | $1,091 | $57 |
| Lamotrigine | 28 | $1,053 | $38 |
| Donepezil | 20 | $1,017 | $51 |
| Quetiapine | 11 | $902 | $82 |
| Naratriptan | 17 | $744 | $44 |
| Baclofen | 23 | $713 | $31 |
| Clonazepam | 21 | $477 | $23 |
| Sertraline | 11 | $344 | $31 |
| Propranolol | 22 | $286 | $13 |
| Citalopram Hbr | 17 | $241 | $14 |
| Fluoxetine | 13 | $198 | $15 |
| Trazodone | 13 | $188 | $14 |
| Nortriptyline | 12 | $160 | $13 |
2013: 21 drugs
| Copaxone | 15 | $62,650 | $4,177 |
| Avonex | 13 | $50,648 | $3,896 |
| Carbidopa-Levodopa | 136 | $15,718 | $116 |
| Ropinirole | 57 | $9,716 | $170 |
| Gabapentin | 67 | $8,821 | $132 |
| Sumatriptan | 20 | $6,809 | $340 |
| Levetiracetam | 39 | $4,973 | $128 |
| Carbidopa-Levodopa Er | 35 | $4,777 | $136 |
| Pyridostigmine | 16 | $3,597 | $225 |
| Primidone | 48 | $3,517 | $73 |
| Propranolol | 38 | $2,628 | $69 |
| Pramipexole Dihydrochloride | 29 | $2,323 | $80 |
| Donepezil | 35 | $1,745 | $50 |
| Baclofen | 25 | $1,531 | $61 |
| Topiramate | 25 | $1,301 | $52 |
| Lamotrigine | 23 | $1,143 | $50 |
| Clopidogrel | 16 | $1,136 | $71 |
| Phenytoin Sodium Extended | 12 | $507 | $42 |
| Clonazepam | 20 | $460 | $23 |
| Citalopram Hbr | 19 | $417 | $22 |
| Doxepin | 11 | $202 | $18 |
Money from drug and device companies
$41 in 2023
| 2023 | 1 | 2 | None | $41 |
| 2019 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Paxlovid | $41 | 2 payments
|
See all 2 published payments
| Pfizer | Meals · 2023-08-29 | Paxlovid | $24 |
| Pfizer | Meals · 2023-07-12 | Paxlovid | $17 |
See earlier years (2019)
2019: $23
| LivaNova USA | Vns Therapy | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1306922828
- Licence
- CA G84562California G84562: Current · expires 2028-05-31
- Trained
- State University of Ny Upstate Medical University, 1991
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G845620
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-27
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.